ENVALITH
有機合成薬品工業株式会社 logo

Yuki Gosei Kogyo Co., Ltd.

4531Standard MarketChemicals

有機合成薬品工業株式会社 logo
Yuki Gosei Kogyo Co., Ltd.4531
Reference Indicators

Market Cap

78¥100M

P/E (Forecast)

P/B

0.6x

Dividend Yield (Forecast)

2.82%

ROE

2.4%

EV/EBITDA

8.3x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
12,36112,83912,93215,12815,448
Cost of Sales
10,0059,7909,67211,82012,827
Gross Profit
2,3563,0483,2603,3072,620
SG&A Expenses
1,9422,1512,1342,0912,236
Operating Income
4138971,1251,216383
Non-operating Income
8081746682
Non-operating Expenses
9631769143162
Ordinary Income
3976601,1301,139303
Extraordinary Income
31361181,915
Extraordinary Losses
107502611321,856
Pre-tax Income
2896419051,124361
Income Taxes
418412922848
Net Income
248556776896313
EBITDA
1,3101,8252,1022,2501,621
Gross Margin
19.1%23.7%25.2%21.9%17.0%
Operating Margin
3.3%7.0%8.7%8.0%2.5%
ROA
1.2%2.5%3.2%3.3%1.2%
ROE
2.3%5.0%6.8%7.0%2.4%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
ファインケミカル事業000.0%
経営管理部門000.0%
営業部門000.0%
研究開発部門000.0%
生産部門000.0%
その他000.0%